| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |